BCAX — BICARA THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BCAX?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 4 tracked investors who changed their BCAX position last quarter, 4 bought and 0 sold (100% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +4 tracked investors added or increased positions last quarter (Paul Tudor Jones, Steve Cohen, Izzy Englander, …)
- +4 tracked investors reported holding BCAX at their latest filing
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About BICARA THERAPEUTICS INC (BCAX)
BICARA THERAPEUTICS INC (BCAX) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $34M. Across recent filings, tracked investors recorded 9 new positions, 5 increased, 5 reduced, and 5 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BCAX
How many top investors track BCAX
A small number of top investors own this.
BCAX Ownership Composition
How BICARA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant98.6%
- Macro1.4%
Tracked investors currently reporting BCAX
1 tracked investor has since exited this position — listed separately below.
- Ken GriffinSep 30, 2026Citadel AdvisorsShares1.1MValue$21.3M% Portfolio0.00%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares591KValue$11M% Portfolio0.00%
- Steve CohenSep 30, 2026Point72 Asset ManagementShares627.1KValue$11.7M% Portfolio0.01%
- Paul Tudor JonesSep 30, 2026Tudor Investment CorpShares33.1KValue$615.7K% Portfolio0.00%
Previously held BCAX
These investors reported BCAX in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| George Soros | Soros Fund Management | 20K | $509.4K | Sep 30, 2024 |
Recent activity
- $615.7KNov 16, 2026
- Increased$11M(125.36%)Nov 16, 2026
- New$11.7MNov 16, 2026
- Increased$21.3M(276.94%)Nov 16, 2026
- $7.6MNov 14, 2024
- Increased$6.7M(28.66%)Feb 14, 2025
- Reduced$334.2K(-93.35%)May 15, 2025
- Increased$6.9M(2789.19%)Aug 14, 2025
- Reduced$7.3M(-57.17%)Feb 17, 2026
- Reduced$3.1M(-63.95%)May 15, 2026
- Increased$7.8M(67.36%)Aug 14, 2026
- Sold$0(-100.00%)Feb 14, 2025
- New$6MNov 14, 2024
- New$2.1MAug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Reduced$9M(-82.45%)Aug 14, 2026
- New$9.5MNov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- New$2MAug 14, 2025
- Reduced$475.9K(-86.10%)Nov 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- $295.7KDec 9, 2025
- Sold$0(-100.00%)May 15, 2026
- New$509.4KNov 14, 2024
Frequently asked questions
- How many institutional investors hold BCAX?
- 4 tracked institutional investors disclosed a position in BCAX (BICARA THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of BCAX?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BCAX, valued at $34M.
- Did institutional ownership of BCAX increase or decrease?
- Across recent 13F filings, tracked investors recorded 9 new positions, 5 increased, 5 reduced, and 5 fully exited BCAX.
- Where does this BCAX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.